| Literature DB >> 23596985 |
Henry C Kariuki, Henry Madsen, John H Ouma, Anthony E Butterworth, David W Dunne, Mark Booth, Gachuhi Kimani, Joseph K Mwatha, Eric Muchiri, Birgitte J Vennervald.
Abstract
BACKGROUND: Schistosoma mansoni infection is a persistent public health problem in many Kenyan communities. Although praziquantel is available, re-infection after chemotherapy treatment is inevitable, especially among children. Chemotherapy followed by intermittent mollusciciding of habitats of Biomphalaria pfeifferi, the intermediate host snail, may have longer term benefits, especially if timed to coincide with natural fluctuations in snail populations.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23596985 PMCID: PMC3652733 DOI: 10.1186/1756-3305-6-107
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Figure 1The two study streams. The stippled line indicates the Nairobi–Mombasa road and stars the sampling sites. Sites were numbered consequtively from T1 (S2° 28′ 24.96″; E38° 3′ 12.12″) to T11 (S2° 23′ 54.00″; E38° 9′ 20.64″) in the Thange stream (Non-intervention) and from K1 (S2° 34′ 1.17″ E38° 7′ 3.46″) to K11 (S2° 35′ 56.71″; E38° 9′ 47.14″) in the Kambu stream (Intervention). Ulilinzi and Darajani show the approximate position of schools in the two communities.
Figure 2Numbers of (open columns) and infected snails (black columns) per month per site in two streams, Thange a) and Kambu b), during the pre-intervention years (1993 and 1994) and the first year of mollusciciding, together with rainfall c).
Figure 3Total number of collected in each site (Figure1) during the two pre-intervention years, 1993 and 1994. A few of these sites were excluded from the follow-up analysis.
Figure 4Mean total number of (a) and number of infected (b) collected per site per year during 1994 to 2005, together with rainfall (c). Error bars represents 95% CL.
Figure 5Prevalence (a) of infection and heavy infections (black bars) and intensity of infection (b) by age group in the intervention and non-intervention area at base line. Error bars represents 95% CL.
Number of people found infected, maximum intensity of infection and geometric mean intensity of infection in the non-intervention and intervention areas in Makueni District, Kenya
| | ||||||
|---|---|---|---|---|---|---|
| | | | | | | |
| Negative | 22 | 194 | | | | |
| Positive | 154 | 380 | 1440 | 3340 | 90 (70–117) | 77 (65–92) |
| Positive also at follow-up | 32 | 56 | 1403 | 1303 | 179 (101–318) | 99 (68–145) |
| | | | | | | |
| New cases | 1 | 5 | 420 | 25 | 420 | 11 (4–26) |
| Positive pre-treatment | 32 | 56 | 300 | 1000 | 29 (20–42) | 20 (13–29) |
| | | | | | | |
| New cases | 63 | 43 | 470 | 750 | 20 (14–30) | 11 (6–18) |
| Positive at follow-up | 24 | 31 | 407 | 1103 | 24 (13–45) | 21 (12–38) |
| | | | | | | |
| New cases | 18 | 32 | 397 | 525 | 8 (4–14) | 11 (7–17) |
| Positive at survey 1 | 36 | 35 | 1333 | 655 | 8 (5–13) | 20 (11–34) |
| | | | | | | |
| New cases | 94 | 36 | 557 | 303 | 22 (17–28) | 9 (6–15) |
| Positive at survey 2 | 45 | 40 | 1380 | 417 | 26 (16–42) | 21 (13–32) |
| | | | | | | |
| New cases | 17 | 47 | 523 | 743 | 15 (7–32) | 9 (7–13) |
| Positive at survey 3 | 78 | 45 | 2527 | 833 | 48 (32–72) | 29 (17–47) |
*) treatment was given in October 1996 and this survey was conducted 5 weeks post-treatment in the non-intervention area, while a second treatment was given in January 1997 in the intervention area and the survey data presented here are from 4 months post-treatment.
Figure 6Prevalence (a) of infection and heavy infections (black bars) and intensity of infection (b) as geometric mean by year in the intervention and non-intervention areas. Error bars represents 95% CL. The baseline was from October 1996, while surveys 1–4 were from November in the Intervention area and the following January in the Non-intervention area during the years 1997/1998, 1998/1999, 1999/2000 and 2000/2001, respectively.